XML 23 R6.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Shareholders' Equity (Unaudited) - USD ($)
shares in Millions, $ in Millions
Total
Ordinary Shares and Additional Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Loss, Net of Tax
Non- controlling Interests
Beginning Balance (in shares) at Dec. 31, 2019   232.1      
Beginning Balance at Dec. 31, 2019 $ 3,443 $ 6,154 $ 1,248 $ (4,033) $ 74
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 791   772   19
Shares issued - employee stock compensation plans (in shares)   1.2      
Shares issued - employee stock compensation plans (112) $ (112)      
Shares purchased (in shares)   (2.2)      
Shares purchased (463)   (463)    
Share-based compensation expense 81 $ 81      
Dividends to shareholders (102)   (102)    
Net change in fair value of financial instruments (5)     (5)  
Net foreign currency translation adjustments (397)     (395) (2)
Net postretirement benefit obligation 24     24  
Ending Balance (in shares) at Mar. 31, 2020   231.1      
Ending Balance at Mar. 31, 2020 3,260 $ 6,123 1,455 (4,409) 91
Beginning Balance (in shares) at Dec. 31, 2019   232.1      
Beginning Balance at Dec. 31, 2019 3,443 $ 6,154 1,248 (4,033) 74
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 1,202        
Net change in fair value of financial instruments (2)        
Net foreign currency translation adjustments (309)        
Net postretirement benefit obligation 47        
Ending Balance (in shares) at Jun. 30, 2020   231.5      
Ending Balance at Jun. 30, 2020 3,695 $ 6,146 1,751 (4,296) 94
Beginning Balance (in shares) at Mar. 31, 2020   231.1      
Beginning Balance at Mar. 31, 2020 3,260 $ 6,123 1,455 (4,409) 91
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 411   398   13
Shares issued - employee stock compensation plans (in shares)   0.4      
Shares issued - employee stock compensation plans (45) $ (45)      
Share-based compensation expense 64 64      
Dividends to shareholders (102)   (102)    
Net change in fair value of financial instruments 3     3  
Net foreign currency translation adjustments 88     87 1
Net postretirement benefit obligation 23     23  
Purchases of subsidiary shares from noncontrolling interests 0 $ 4     (4)
Dividends paid to noncontrolling interests on subsidiary common stock (7)       (7)
Ending Balance (in shares) at Jun. 30, 2020   231.5      
Ending Balance at Jun. 30, 2020 $ 3,695 $ 6,146 1,751 (4,296) 94
Beginning Balance (in shares) at Dec. 31, 2020 225.5 225.5      
Beginning Balance at Dec. 31, 2020 $ 3,583 $ 6,314 1,042 (3,861) 88
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 933   913   20
Shares issued - employee stock compensation plans (in shares)   0.9      
Shares issued - employee stock compensation plans (87) $ (87)      
Shares purchased (in shares)   (0.2)      
Shares purchased (50)   (50)    
Share-based compensation expense 131 $ 131      
Dividends to shareholders (104)   (104)    
Net change in fair value of financial instruments 11     11  
Net foreign currency translation adjustments (70)     (70)  
Net postretirement benefit obligation 29     29  
Purchases of subsidiary shares from noncontrolling interests (14) $ (8)     (6)
Dividends paid to noncontrolling interests on subsidiary common stock (1)       (1)
Ending Balance (in shares) at Mar. 31, 2021   226.2      
Ending Balance at Mar. 31, 2021 $ 4,361 $ 6,350 1,801 (3,891) 101
Beginning Balance (in shares) at Dec. 31, 2020 225.5 225.5      
Beginning Balance at Dec. 31, 2020 $ 3,583 $ 6,314 1,042 (3,861) 88
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 1,326        
Net change in fair value of financial instruments 10        
Net foreign currency translation adjustments 45        
Net postretirement benefit obligation $ 62        
Ending Balance (in shares) at Jun. 30, 2021 225.6 225.6      
Ending Balance at Jun. 30, 2021 $ 4,567 $ 6,383 1,823 (3,744) 105
Beginning Balance (in shares) at Mar. 31, 2021   226.2      
Beginning Balance at Mar. 31, 2021 4,361 $ 6,350 1,801 (3,891) 101
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 393   379   14
Shares issued - employee stock compensation plans (in shares)   0.5      
Shares issued - employee stock compensation plans (52) $ (52)      
Shares purchased (in shares)   (1.1)      
Shares purchased (242)   (242)    
Share-based compensation expense 85 $ 85      
Dividends to shareholders (115)   (115)    
Net change in fair value of financial instruments (1)     (1)  
Net foreign currency translation adjustments 115     115  
Net postretirement benefit obligation 33     33  
Dividends paid to noncontrolling interests on subsidiary common stock $ (10)       (10)
Ending Balance (in shares) at Jun. 30, 2021 225.6 225.6      
Ending Balance at Jun. 30, 2021 $ 4,567 $ 6,383 $ 1,823 $ (3,744) $ 105